Atnaujinkite slapukų nuostatas

El. knyga: Laboratory Medicine in Psychiatry and Behavioral Science

  • Formatas: 388 pages
  • Išleidimo metai: 19-Dec-2016
  • Leidėjas: American Psychiatric Association Publishing
  • Kalba: eng
  • ISBN-13: 9781615371211
  • Formatas: 388 pages
  • Išleidimo metai: 19-Dec-2016
  • Leidėjas: American Psychiatric Association Publishing
  • Kalba: eng
  • ISBN-13: 9781615371211

DRM apribojimai

  • Kopijuoti:

    neleidžiama

  • Spausdinti:

    neleidžiama

  • El. knygos naudojimas:

    Skaitmeninių teisių valdymas (DRM)
    Leidykla pateikė šią knygą šifruota forma, o tai reiškia, kad norint ją atrakinti ir perskaityti reikia įdiegti nemokamą programinę įrangą. Norint skaityti šią el. knygą, turite susikurti Adobe ID . Daugiau informacijos  čia. El. knygą galima atsisiųsti į 6 įrenginius (vienas vartotojas su tuo pačiu Adobe ID).

    Reikalinga programinė įranga
    Norint skaityti šią el. knygą mobiliajame įrenginyje (telefone ar planšetiniame kompiuteryje), turite įdiegti šią nemokamą programėlę: PocketBook Reader (iOS / Android)

    Norint skaityti šią el. knygą asmeniniame arba „Mac“ kompiuteryje, Jums reikalinga  Adobe Digital Editions “ (tai nemokama programa, specialiai sukurta el. knygoms. Tai nėra tas pats, kas „Adobe Reader“, kurią tikriausiai jau turite savo kompiuteryje.)

    Negalite skaityti šios el. knygos naudodami „Amazon Kindle“.

A revised, abridged version of the seminal work, Laboratory Medicine in Psychiatry and Behavioral Science, Clinical Laboratory Medicine for Mental Health Professionals more directly addresses the needs of general psychiatrists and their mental health colleagues in clinical practice. Sections on laboratory tests, diseases and conditions, and psychotropic medications include alphabetically arranged entries, making it easy for busy clinicians to reference the updated information. For each laboratory test, the following information is provided:

The type of test (e.g., blood, urine, etc.)

An explanation of the test

The tests relevance to psychiatry

Patient preparation

Medical and psychiatric indications for the test

Numerical reference ranges

Critical values for test results

The potential meaning of abnormal results (e.g., factors that lead to increased or decreased levels)

Interfering factors

Cross-references to other tests or conditions Information on clinical diagnosis and laboratory testing is provided for diseases and conditions, and psychotropic medications are examined from both a screening and a monitoring standpoint.

Extensively indexed, this guide also includes an appendix that features at-a-glance information on therapeutic and psychotropic levels, 10 rules for deciding whether an ECG is normal, and several figures covering topics relevant to tests, such as ECG waves and intervals, cholestatic injury, bilirubin cycle, and SIADH secretion. Years of clinical practice and research inform both the choice of tests included and the rationale for their use, making Clinical Laboratory Medicine for Mental Health Professionals the definitive, authoritative reference for psychiatrists and other behavioral health clinicians.

Recenzijos

This handy book would be very helpful to general psychiatrists or behavioral health practitioners wanting basic and concise information on commonly used clinical laboratory tests in the treatment and management of psychiatric disorders. -- Valerie L. Ng, Ph.D., M.D. * Doody's Book Review *

Preface xi
Introduction xiii
About the Author xvii
Chapter 1 Laboratory Tests
1(178)
Alanine transaminase (ALT)
2(3)
Albumin
5(2)
Alkaline phosphatase (ALP)
7(3)
Alprazolam level
10(1)
Ammonia (NH3)
11(2)
Amylase
13(2)
Antinuclear antibody (ANA) test
15(3)
Apolipoprotein E (ApoE) genotyping
18(1)
Aspartate transaminase (AST)
19(3)
Basic metabolic panel (BMP)
22(1)
Bilirubin
23(3)
Blood alcohol level (BAL)
26(2)
Blood urea nitrogen (BUN)
28(2)
Calcium (Ca++)
30(4)
Carbamazepine level
34(1)
Carbohydrate-deficient transferrin (CDT or %CDT)
35(2)
Carbon dioxide (CO2)
37(2)
Chest X ray (CXR)
39(2)
Chlordiazepoxide level
41(1)
Chloride (Cl-)
42(2)
Clonazepam level
44(1)
Clozapine level
45(1)
Complete blood count (CBC)
46(2)
Comprehensive metabolic panel (CMP)
48(1)
Cranial computed tomography (head CT or CAT scan)
49(3)
Creatine kinase (CK) (also known as creatine phosphokinase [ CPK])
52(4)
Creatinine (Cr)
56(3)
Cytochrome P450 (CYP450) genotyping: AmpliChip CYP450 test
59(2)
Diazepam level
61(1)
Drug screen (toxicology screen)
62(3)
Electrocardiogram (ECG or EKG)
65(3)
Electroencephalogram (EEG)
68(3)
Electrolytes panel
71(1)
Ethylene glycol level
72(1)
Flurazepam level
73(1)
Folate (also known as folic acid)
74(2)
Gamma-glutamyltransferase (GGT)
76(2)
Glucose (blood sugar)
78(3)
Hematocrit (Hct)
81(2)
Hemoglobin (Hb)
83(2)
Hemoglobin A1C (HbA1C)
85(2)
Hepatitis panel
87(2)
HIV testing
89(2)
Lipase
91(2)
Lipid panel
93(4)
Lithium level
97(2)
Liver function tests (LFTs)
99(3)
Lorazepam level
102(1)
Magnesium (Mg++)
103(3)
Magnetic resonance imaging (MRI)
106(4)
Mean corpuscular volume (MCV)
110(2)
Methanol level
112(1)
Multiple sleep latency test (MSLT); maintenance of wakefulness test (MWT)
113(2)
Osmolality (serum and urine)
115(4)
Oxazepam level
119(1)
Phosphate (also known as phosphorus)
120(3)
Platelet count
123(3)
Polysomnography (PSG)
126(2)
Positron emission tomography (PET): brain
128(2)
Potassium (K+)
130(3)
Prealbumin
133(2)
Prolactin (PRL)
135(3)
Protein
138(2)
Pyridoxine (vitamin B6)
140(2)
Red blood cell count (RBC)
142(2)
Renal function panel
144(1)
Single-photon emission computed tomography (SPECT)
145(2)
Sodium (Na+)
147(2)
Syphilis testing
149(2)
Temazepam level
151(1)
Thiamine (vitamin B1)
152(2)
Thyroid function testing: free thyroxine (free T4; FT4)
154(2)
Thyroid function testing: thyroid-stimulating hormone (TSH)
156(3)
Triglycerides
159(3)
Tuberculosis (TB) testing
162(2)
Uric acid
164(2)
Urinalysis (UA)
166(3)
Valproate level
169(1)
Vitamin B12
170(2)
Vitamin D
172(2)
White blood cell count (WBC)
174(2)
Wilson disease screening panel
176(3)
Chapter 2 Diseases and Conditions
179(60)
Alcohol use disorder (alcoholism)
180(2)
Anorexia nervosa
182(2)
Anxiety disorder (secondary): substance/medication-induced or due to another medical condition
184(1)
Attention-deficit/hyperactivity disorder (ADHD)
185(1)
Autism spectrum disorder (ASD)
186(1)
Catatonia disorder due to another medical condition
187(1)
Delirium
188(2)
Diabetes mellitus
190(1)
Down syndrome (trisomy 21)
191(1)
Eating disorders
192(2)
Ethylene glycol poisoning
194(1)
Fatty liver disease (nonalcoholic)
195(1)
Folate deficiency
196(1)
Generalized anxiety disorder (GAD)
197(1)
Hepatic encephalopathy (HE)
198(2)
Hepatitis (viral)
200(1)
HIV/AIDS
201(2)
Hydrocephalus
203(1)
Hyperthyroidism
204(2)
Hypothyroidism
206(1)
Intellectual disability
207(1)
Lead poisoning
208(2)
Major depressive episode
210(1)
Manic episode
211(2)
Metabolic syndrome
213(1)
Methanol poisoning
214(1)
Neuroleptic malignant syndrome (NMS)
215(1)
Obsessive-compulsive disorder (OCD)
216(1)
Panic attack; panic disorder
217(2)
Pica
219(1)
Polydipsia (psychogenic)
220(1)
Psychotic disorder due to another medical condition
221(2)
Restless legs syndrome (RLS)
223(1)
Sarcoidosis
224(2)
Schizophrenia
226(2)
Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
228(2)
Thiamine (vitamin B1) deficiency
230(2)
Tuberculosis (TB)
232(2)
Vitamin B12 deficiency
234(2)
Wernicke-Korsakoff syndrome
236(3)
Chapter 3 Psychotropic Medications: Laboratory Screening and Monitoring
239(38)
Acamprosate (Campral)
240(1)
Amphetamines (Adderall); dextroamphetamines (Dexedrine); lisdexamfetamine dimesylate (Vyvanse)
241(1)
Antipsychotic medications, first-generation (typical)
242(1)
Antipsychotic medications, second-generation (atypical)
243(1)
Atomoxetine (Strattera)
244(1)
Benzodiazepines
245(1)
Buprenorphine (Buprenex, Subutex); buprenorphine/naloxone (Suboxone)
246(1)
Bupropion (Aplenzin, Budeprion SR, Wellbutrin)
247(1)
Buspirone
248(1)
Carbamazepine
249(1)
Clozapine (Clozaril, FazaClo, Versacloz)
250(2)
Donepezil (Aricept)
252(1)
Duloxetine (Cymbalta)
253(1)
Gabapentin
254(1)
Galantamine (Razadyne)
255(1)
Lamotrigine (Lamictal)
256(1)
Levetiracetam (Keppra)
257(1)
Lithium
258(1)
Methylphenidate (Ritalin, Concern)
259(1)
Mirtazapine (Remeron)
260(1)
Monoamine oxidase inhibitors (MAOIs)
261(1)
Naltrexone (ReVia, Vivitrol)
262(1)
Nefazodone
263(1)
Nonbenzodiazepine hypnotics: eszopiclone (Lunesta), zaleplon (Sonata), Zolpidem (Ambien, Edluar, Intermezzo, Zolpimist)
264(1)
Opioids
265(1)
Oxcarbazepine (Trileptal)
266(1)
Ramelteon (Rozerem)
267(1)
Rivastigmine (Exelon)
268(1)
Selective serotonin reuptake inhibitors (SSRIs)
269(1)
Topiramate (Topamax)
270(1)
Tramadol (Ultram)
271(1)
Trazodone (Desyrel, Oleptro)
272(1)
Tricyclic antidepressants (TCAs)
273(2)
Valproate
275(1)
Venlafaxine (Effexor); desvenlafaxine (Pristiq)
276(1)
Appendix
277(10)
Therapeutic and Toxic Drug Levels at a Glance
279(1)
Ten Rules for a Normal Electrocardiogram
280(7)
Figure 1 The Electrocardiogram: Waves and Intervals
281(1)
Figure 2 Hy's Law
282(1)
Figure 3 Cholestatic Injury
282(1)
Figure 4 Bilirubin Cycle
283(1)
Figure 5 Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
284(3)
References 287(8)
Index 295
Sandra A. Jacobson, M.D., is with the University of Arizona College of Medicine Phoenix in Phoenix, Arizona.